机构:[1]Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China[2]Tianjin Medical University General Hospital, Tianjin, China[3]Tianjin Medical University Cancer Institute and Hospital, Tianjin, China[4]Hebei University, Shijiazhuang, China[5]Shanxi Traditional Chinese Medicine Hospital, Taiyuan, China[6]The First Affiliated Hospital of the Chinese People's Liberation Army General, Beijing, China[7]Shanxi Provincial Cancer Hospital, Taiyuan, China[8]Affiliated Peace Hospital of Changzhi Medical College, Changzhi, China[9]First Hospital of Qinhuangdao, Qin Huang Dao, China[10]Hebei University Hospital, Baoding, China[11]Shanxi Dayi Hospital, Taiyuan, China山西白求恩医院[12]Second People’s Hospital of Datong, Datong, China[13]First People’s Hospital of Yangquan, Yangquan, China[14]Cangzhou Central Hospital, Cangzhou, China[15]First People’s Hospital of Tianjin, Tianjin, China[16]Xingtai People’s Hospital, Xingtai, China[17]Second Hospital of Shanxi Medical University, Taiyuan, China[18]Peking University Third Hospital, Beijing, China[19]Shanxi University of Traditional Chinese Medicine, Taiyuan, China[20]Pekeing University Binhai Hospital, Tianjin, China
第一作者机构:[1]Peking Union Medical College Hospital/ Chinese Academy of Medical Sciences, Beijing, China
推荐引用方式(GB/T 7714):
Bai Chunmei,Zhong Diansheng,Ren Xiu-Bao,et al.Apatinib in patients with adenocarcinoma of stomach or gastroesophageal junction: A prospective, multicenter, non-interventional study (Ahead-G202)[J].JOURNAL OF CLINICAL ONCOLOGY.2018,36(15):doi:10.1200/JCO.2018.36.15_suppl.e16047.
APA:
Bai, Chunmei,Zhong, Diansheng,Ren, Xiu-Bao,Zhang, Ruixing,Liu, Likun...&Li, Guozhong.(2018).Apatinib in patients with adenocarcinoma of stomach or gastroesophageal junction: A prospective, multicenter, non-interventional study (Ahead-G202).JOURNAL OF CLINICAL ONCOLOGY,36,(15)
MLA:
Bai, Chunmei,et al."Apatinib in patients with adenocarcinoma of stomach or gastroesophageal junction: A prospective, multicenter, non-interventional study (Ahead-G202)".JOURNAL OF CLINICAL ONCOLOGY 36..15(2018)